Contracts › 75A50123C00040
75A50123C00040: Nplate Administration Kit Development for the Treatment of Approved Indications, Including Acute Radiation Syndrome (ARS)
Awarded to Amgen Inc. by Office of Assistant Secretary for Preparedness and Response.
$7.3Mobligated
$7.3Mpotential value
30 June 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50123C00040 |
|---|---|
| Awardee | Amgen Inc. |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 325412 Pharmaceutical Preparation Manufacturing |
| PSC | 6505 Drugs and Biologicals |
| Place of performance | CA |
| Offers received | 1 |
| Period of performance | 28 August 2023 to 30 June 2028 |
| Potential end | 30 June 2028 |
| Estimated recompete solicitation | ~Q1 2028 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325412 contracts · All expiring contracts · USASpending record